Skip to content

Lyophilized Beads Webinar with Dr. Maria Badal Tejedor, June 29th at 10:00 AM ET LEARN MORE


Lyophilized Beads: Freeze-drying Cycle Parameters Considerations in Relation to Formulation Characteristics

Lyophilized beads are spheres made of lyophilized material containing a certain concentration of selected components. They are a very versatile system that provides long term stability, quick reconstitution, and easy handling.

Read More

In-Situ Vial Strain Measurements During Freeze/Thaw Processes Using Amorphous Excipients

In lyophilized drug and biological products, crystallization of ice and excipients impart stresses on the walls of the vial which can be detected with a strain gauge. During the freezing process of lyophilization, there can be significant sample loss from vial breakage leading to loss of process control and additional cleaning expenses.

Read More

Tissue Freeze Drying – Photocrosslinkable Extracellular Matrices for Re-creating an In Vivo Environment in Research

The rigidity (stiffness) of the substrate to which cells adhere can have a profound effect on cell propagation, differentiation, lineage specification, gene expression, morphology, self-renewal, pluripotency and migration.

Read More

Sensitivity of Lyophilization Rate and Porous Structure to Small Changes in Freezing

This webinar will highlight the influence of controllable factors such as ice nucleation temperature and post nucleation shelf-cooling rate on the primary drying rate, dry product resistance and porous structure characterized by pore size distribution, specific surface area and X-ray microCT imaging.

Read More

From MicroFD® to “Macro” Freeze Dryers and Vice Versa: A Groundbreaking Tool for Innovation in Freeze Drying

The MicroFD by Millrock Technology offers unique features for freeze drying practitioners. Few vials are processed, thus minimizing the cost of process development and shortening the stages of batch preparation & loading, condenser defrosting, etc.

Read More

Introduction to Vial Fogging and Mitigation Strategies

Vial fogging is a phenomenon commonly observed in lyophilized biologic drug products and has been widely reported in the pharmaceutical industry. The appearance of vial fogging presents as a haze of dried powder which is visible above where the dried cake meets the inner surface of the vials.

Read More

Considerations for Bulk Freeze Drying

In the freeze drying world, most of the work and literature published is related to vial freeze drying and does not touch on some of the differences that are only seen when working with bulk materials. This webinar will highlight some of the most common challenges users face when freeze drying bulk material as well as some of the features that users should be attentive to when selecting a freeze dryer to be used in a bulk application.

Read More

Lyophilized Drug Product Case Study: Risk Mitigation of Primary Packaging through Physical and Chemical Testing

Accelerate your lyophilized drug development by de-risking your primary packaging selection. Physical and chemical properties of a container closure system for parenterals may affect the drug manufacturing process, product quality and patient safety. In the case of a lyophilized product, the risks are mainly associated with design for manufacturability and impact on product quality.

Read More

Next Generation Vials for COVID-19 Vaccines and Cell and Gene Therapies

The emergence of cell and gene therapies and new COVID-19 vaccines brings the promise of treating some of the most challenging diseases. Storage, transport, and delivery of these breakthrough therapies for safe clinical use has its own set of challenges.

Read More

Pharmaceutical Development of Antibody Drug Conjugates, Live with Q&A

Antibody drug conjugates (ADCs) are antibodies equipped with a small number of chemotherapeutic molecules with the aid of a linker system.  They have grown in importance because the antibody targets specific cells where they drop off their payload of chemotherapeutic molecules.  This is a huge advantage to chemotherapy. 

Read More
Contact US